Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B

References

• Aguilar JC, Lobaina Y, Muzio V, García D, Pentón E, Iglesias E, Pichardo D, Urquiza D, Rodríguez D, Silva D, Petrovsky N, Guillén G. (2004). Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen. Immunol Cell Biol, 82: 539–546.
   Google Scholar
• Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W. (2006). Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release, 111: 107–116.
   PubMed Web of Science ®Google Scholar
• Baldridge JR, Yorgensen Y, Ward JR, Ulrich JT. (2000). Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration. Vaccine, 18: 2416–2425.
   PubMed Web of Science ®Google Scholar
• Barr IG, Mitchell GF. (1996). ISCOMs (immunostimulating complexes): the first decade. Immunol Cell Biol, 74: 8–25.
   PubMed Web of Science ®Google Scholar
• Betancourt AA, Delgado CA, Estévez ZC, Martínez JC, Ríos GV, Aureoles-Roselló SR, Zaldívar RA, Guzmán MA, Baile NF, Reyes PA, Ruano LO, Fernández AC, Lobaina-Matos Y, Fernández AD, Madrazo AI, Martínez MI, Baños ML, Alvarez NP, Baldo MD, Mestre RE, Pérez MV, Martínez ME, Escobar DA, Guanche MJ, Cáceres LM, Betancourt RS, Rando EH, Nieto GE, González VL, Rubido JC. (2007). Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens. Int J Infect Dis, 11: 394–401.
   PubMed Web of Science ®Google Scholar
• Bharali DJ, Mousa SA, Thanavala Y. (2007). Micro- and nanoparticle-based vaccines for hepatitis B. Adv Exp Med Biol, 601: 415–421.
   PubMed Web of Science ®Google Scholar
• Borges O, Cordeiro-da-Silva A, Tavares J, Santarém N, de Sousa A, Borchard G, Junginger HE. (2008). Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles. Eur J Pharm Biopharm, 69: 405–416.
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. (2003). Role of secretory antibodies in the defence against infections. Int J Med Microbiol, 293: 3–15.
   PubMed Web of Science ®Google Scholar
• Chen M, Hu KF, Rozell B, Orvell C, Morein B, Liljeström P. (2002). Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus. J Immunol, 169: 3208–3216.
   PubMed Web of Science ®Google Scholar
• Cox E, Verdonck F, Vanrompay D, Goddeeris B. (2006). Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa. Vet Res, 37: 511–539.
   PubMed Web of Science ®Google Scholar
• Csaba N, Garcia-Fuentes M, Alonso MJ. (2009). Nanoparticles for nasal vaccination. Adv Drug Deliv Rev, 61: 140–157.
   PubMed Web of Science ®Google Scholar
• Davis HL, Michel ML, Whalen RG. (1993). DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet, 2: 1847–1851.
   PubMed Web of Science ®Google Scholar
• Daynes RA, Enioutina EY, Butler S, Mu HH, McGee ZA, Araneo B A. (1996). Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infect Immun, 64: 1100–1109.
   PubMed Web of Science ®Google Scholar
• Debin A, Kravtzoff R, Santiago JV, Cazales L, Sperandio S, Melber K, Janowicz Z, Betbeder D, Moynier M. (2002). Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses. Vaccine, 20: 2752–2763.
   PubMed Web of Science ®Google Scholar
• Demana PH, Davies NM, Berger B, Rades T. (2004). Incorporation of ovalbumin into ISCOMs and related colloidal particles prepared by the lipid film hydration method. Int J Pharm, 278: 263–274.
   PubMed Web of Science ®Google Scholar
• Garcia JL, Gennari SM, Navarro IT, Machado RZ, Sinhorini IL. (2004). Toxoplasma gondii: isolation of tachyzoites rhoptries and incorporation into Iscom. Exp Parasitol, 108: 40–46.
   PubMed Web of Science ®Google Scholar
• Giudice EL, Campbell JD. (2006). Needle-free vaccine delivery. Adv Drug Deliv Rev, 58: 68–89.
   PubMed Web of Science ®Google Scholar
• Gupta RK. (1998). Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev, 32: 155–172.
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. (2005). Mucosal immunity and vaccines. Nat Med, 11: S45–S53.
   PubMed Web of Science ®Google Scholar
• Hu KF, Lövgren-Bengtsson K, Morein B. (2001). Immunostimulating complexes (ISCOMs) for nasal vaccination. Adv Drug Deliv Rev, 51: 149–159.
   PubMed Web of Science ®Google Scholar
• Isaka M, Yasuda Y, Mizokami M, Kozuka S, Taniguchi T, Matano K, Maeyama J, Mizuno K, Morokuma K, Ohkuma K, Goto N, Tochikubo K. (2001). Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant. Vaccine, 19: 1460–1466.
   PubMed Web of Science ®Google Scholar
• Jaganathan KS, Vyas SP. (2006). Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine, 24: 4201–4211.
   PubMed Web of Science ®Google Scholar
• Kersten GF, Spiekstra A, Beuvery EC, Crommelin DJ. (1991). On the structure of immune-stimulating saponin-lipid complexes (iscoms). Biochim Biophys Acta, 1062: 165–171.
   PubMed Web of Science ®Google Scholar
• Kido H, Mizuno D, Takei T. (2008). Nasal vaccines. Nippon Rinsho, 66: 1881–1887.
   PubMedGoogle Scholar
• Lazorová L, Artursson P, Engström A, Sjölander A. (1996). Transport of an influenza virus vaccine formulation (iscom) in Caco-2 cells. Am J Physiol, 270: G554–G564.
   PubMed Web of Science ®Google Scholar
• Lindblad EB. (2004). Aluminium compounds for use in vaccines. Immunol Cell Biol, 82: 497–505.
   PubMed Web of Science ®Google Scholar
• Lövgren K, Kåberg H, Morein B. (1990). An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration. Clin Exp Immunol, 82: 435–439.
   PubMed Web of Science ®Google Scholar
• Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, Steinman RM. (2000). The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol, 151: 673–684.
   PubMed Web of Science ®Google Scholar
• Makidon PE, Bielinska AU, Nigavekar SS, Janczak KW, Knowlton J, Scott AJ, Mank N, Cao Z, Rathinavelu S, Beer MR, Wilkinson JE, Blanco LP, Landers JJ, Baker JR Jr. (2008). Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine. PLoS ONE, 3: e2954.
   PubMed Web of Science ®Google Scholar
• McCluskie MJ, Davis HL. (1998). Cutting edge: CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J Immunol, 161: 4463–4466.
   PubMed Web of Science ®Google Scholar
• Morein B, Hu KF, Abusugra I. (2004). Current status and potential application of ISCOMs in veterinary medicine. Adv Drug Deliv Rev, 56: 1367–1382.
   PubMed Web of Science ®Google Scholar
• Morein B, Villacrés-Eriksson M, Ekström J, Hu K, Behboudi S, Lövgren-Bengtsson K. (1999). ISCOM: a delivery system for neonates and for mucosal administration. Adv Vet Med, 41: 405–413.
   PubMedGoogle Scholar
• Mowat AM, Smith RE, Donachie AM, Furrie E, Grdic D, Lycke N. (1999). Oral vaccination with immune stimulating complexes. Immunol Lett, 65: 133–140.
   PubMed Web of Science ®Google Scholar
• Neutra MR, Kozlowski PA. (2006). Mucosal vaccines: the promise and the challenge. Nat Rev Immunol, 6: 148–158.
   PubMed Web of Science ®Google Scholar
• Pearse MJ, Drane D. (2005). ISCOMATRIX adjuvant for antigen delivery. Adv Drug Deliv Rev, 57: 465–474.
   PubMed Web of Science ®Google Scholar
• Peek LJ, Middaugh CR, Berkland C. (2008). Nanotechnology in vaccine delivery. Adv Drug Deliv Rev, 60: 915–928.
   PubMed Web of Science ®Google Scholar
• Perrie Y, Frederik PM, Gregoriadis G. (2001). Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine, 19: 3301–3310.
   PubMed Web of Science ®Google Scholar
• Petrovsky N. (2006). Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity. Vaccine, 24 Suppl 2: S2–26.
   PubMed Web of Science ®Google Scholar
• Pittman PR. (2002). Aluminum-containing vaccine associated adverse events: role of route of administration and gender. Vaccine, 20 Suppl 3: S48–S50.
   PubMed Web of Science ®Google Scholar
• Poland GA, Jacobson RM. (2004). Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med, 351: 2832–2838.
   PubMed Web of Science ®Google Scholar
• Sanders MT, Brown LE, Deliyannis G, Pearse MJ. (2005). ISCOM-based vaccines: the second decade. Immunol Cell Biol, 83: 119–128.
   PubMed Web of Science ®Google Scholar
• Sanyal G, Shi L. (2009). A review of multiple approaches towards an improved hepatitis B vaccine. Expert Opin Ther Pat, 19: 59–72.
   PubMed Web of Science ®Google Scholar
• Saraf S, Mishra D, Asthana A, Jain R, Singh S, Jain NK. (2006). Lipid microparticles for mucosal immunization against hepatitis B. Vaccine, 24: 45–56.
   PubMed Web of Science ®Google Scholar
• Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. (2006). Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev, 28: 112–125.
   PubMed Web of Science ®Google Scholar
• Sjölander S, Drane D, Davis R, Beezum L, Pearse M, Cox J. (2001). Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses. Vaccine, 19: 4072–4080.
   PubMed Web of Science ®Google Scholar
• Skene CD, Sutton P. (2006). Saponin-adjuvanted particulate vaccines for clinical use. Methods, 40: 53–59.
   PubMed Web of Science ®Google Scholar
• Slütter B, Hagenaars N, Jiskoot W. (2008). Rational design of nasal vaccines. J Drug Target, 16: 1–17.
   PubMed Web of Science ®Google Scholar
• Smith RE, Donachie AM, Mowat AM. (1991). Immune stimulating complexes as mucosal vaccines. Immunol Cell Biol, 76: 263–269.
   Web of Science ®Google Scholar
• Sun HX, Xie Y, Ye YP. (2009). ISCOMs and ISCOMATRIX. Vaccine, 27: 4388–4401.
   PubMed Web of Science ®Google Scholar
• Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A. (1980). Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med, 303: 833–841.
   PubMed Web of Science ®Google Scholar
• Tleugabulova D. (1998). Sodium dodecylsulfate polyacrylamide gel electrophoresis of recombinant hepatitis B surface antigen particles. J Chromatogr B Biomed Sci Appl, 707: 267–273.
   PubMed Web of Science ®Google Scholar
• Villacres-Eriksson M, Bergström-Mollaoglu M, Kåberg H, Lövgren K, Morein B. (1993). The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells. Clin Exp Immunol, 93: 120–125.
   PubMed Web of Science ®Google Scholar
• Watson DL, Watson NA, Fossum C, Lövgren K, Morein B. (1992). Interactions between immune-stimulating complexes (ISCOMs) and peritoneal mononuclear leucocytes. Microbiol Immunol, 36: 199–203.
   PubMed Web of Science ®Google Scholar
• You J, Sriplung H, Geater A, Chongsuvivatwong V, Zhuang L, Chen HY, Yu L, Tang BZ, Huang JH. (2008). Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B. World J Gastroenterol, 14: 1112–1119.
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Van Damme P, Shouval D. (2008). The global impact of vaccination against hepatitis B: a historical overview. Vaccine, 26: 6266–6273.
   PubMed Web of Science ®Google Scholar
• Zuckerman JN. (2006). Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol, 78: 169–177.
   PubMed Web of Science ®Google Scholar